Group 1: Earnings Performance - HealthEquity reported quarterly earnings of $1.08 per share, exceeding the Zacks Consensus Estimate of $0.92 per share, and up from $0.86 per share a year ago [1] - The earnings surprise for this quarter was +17.39%, following a previous quarter surprise of +19.75% where actual earnings were $0.97 compared to an expected $0.81 [2] - Over the last four quarters, HealthEquity has surpassed consensus EPS estimates three times [2] Group 2: Revenue Performance - The company posted revenues of $325.84 million for the quarter ended July 2025, surpassing the Zacks Consensus Estimate by 2.20%, and up from $299.93 million year-over-year [3] - HealthEquity has topped consensus revenue estimates four times over the last four quarters [3] Group 3: Stock Performance and Outlook - HealthEquity shares have declined approximately 6.9% since the beginning of the year, while the S&P 500 has gained 9.8% [4] - The current consensus EPS estimate for the upcoming quarter is $0.91 on revenues of $318.56 million, and for the current fiscal year, it is $3.73 on $1.3 billion in revenues [8] Group 4: Industry Context - The Medical Services industry, to which HealthEquity belongs, is currently in the top 41% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [9] - Another company in the same industry, PACS Group, Inc., is expected to report quarterly earnings of $0.47 per share, reflecting a year-over-year change of +771.4% [10]
HealthEquity (HQY) Q2 Earnings and Revenues Surpass Estimates